COMPASS Pathways plc
$9.46
▲
3.02%
2026-04-21 06:06:02
compasspathways.com
NMS: CMPS
Explore COMPASS Pathways plc stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$639.93 M
Current Price
$9.46
52W High / Low
$8.9 / $2.25
Stock P/E
—
Book Value
$-0.55
Dividend Yield
—
ROCE
468.11%
ROE
-5.65%
Face Value
—
EPS
$-3.08
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
156
Beta
2.02
Debt / Equity
-0.66
Current Ratio
0.77
Quick Ratio
0.77
Forward P/E
-4.63
Price / Sales
—
Enterprise Value
$598.37 M
EV / EBITDA
-3.42
EV / Revenue
—
Rating
Strong Buy
Target Price
$21.75
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | biote Corp. | $2.24 | 3.25 | $87.8 M | — | 56.77% | -32.89% | $4.75 / $1.27 | $-1.91 |
| 2. | Acadia Healthcare Company, Inc. | $27.84 | — | $2.56 B | — | 7.76% | -40.96% | $28.48 / $11.43 | $21.55 |
| 3. | DocGo Inc. | $0.68 | — | $64.06 M | — | -59.59% | -89.05% | $2.45 / $0.49 | $1.46 |
| 4. | Healthcare Services Group, Inc. | $19.32 | 22.48 | $1.33 B | — | 8.94% | 11.69% | $22.98 / $9.12 | $7.33 |
| 5. | Aveanna Healthcare Holdings Inc. | $6.87 | 6.54 | $1.47 B | — | 16.39% | 6.16% | $10.32 / $3.73 | $0.93 |
| 6. | PACS Group, Inc. | $36 | 28.88 | $5.53 B | — | 6.76% | 22.96% | $43.08 / $7.5 | $6.04 |
| 7. | DaVita Inc. | $149.93 | 15.78 | $10.02 B | — | 14.02% | 64.85% | $159.42 / $101 | $-9.5 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -58.86 M | -36.61 M | -38.65 M | -41.17 M | -38.21 M |
| Net Profit | -93.88 M | -137.72 M | -38.4 M | -17.86 M | -43.33 M |
| EPS in Rs | -0.73 | -1.07 | -0.3 | -0.14 | -0.34 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -175.29 M | -157.11 M | -124.04 M | -95.98 M |
| Net Profit | -287.86 M | -155.12 M | -118.46 M | -91.5 M |
| EPS in Rs | -2.23 | -1.2 | -0.92 | -0.71 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 210.35 M | 213.67 M | 275.99 M | 197.29 M |
| Total Liabilities | 263.2 M | 58.97 M | 50.24 M | 16.01 M |
| Equity | -52.85 M | 154.69 M | 225.74 M | 181.28 M |
| Current Assets | 191.49 M | 201.29 M | 261.3 M | 191.65 M |
| Current Liabilities | 247.79 M | 34.02 M | 19.6 M | 15.6 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -157.24 M | -119.19 M | -97.38 M | -105.45 M |
| Investing CF | — | 0 M | -0.06 M | -0.6 M |
| Financing CF | 140.71 M | 63.82 M | 173.83 M | 1.04 M |
| Free CF | -157.24 M | -119.19 M | -97.44 M | -106.05 M |
| Capex | — | — | -0.07 M | -0.6 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -85.57% | -30.94% | -29.46% | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.